A Phase 1 Study of Venetoclax (ABT-199 / GDC-0199) Monotherapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

被引：70

作者：

Gerecitano, John F. ^{[1
]}

Roberts, Andrew W. ^{[2
,3
]}

Seymour, John F. ^{[4
]}

Wierda, William G. ^{[5
]}

Kahl, Brad S. ^{[6
]}

Pagel, John M. ^{[7
]}

Puvvada, Soham ^{[8
]}

Kipps, Thomas J. ^{[9
]}

Anderson, Mary Ann ^{[2
,3
]}

Dunbar, Martin ^{[10
]}

Zhu, Ming ^{[10
]}

Gressick, Lori ^{[10
]}

Wagner, Lindsay ^{[10
]}

Kim, Su Young ^{[10
]}

Enschende, Sari Heitner ^{[10
]}

Humerickhouse, Rod A. ^{[10
]}

Davids, Matthew S. ^{[11
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia

[3] Royal Melbourne Hosp, Melbourne, Vic, Australia

[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[6] Univ Wisconsin, Madison, WI 53706 USA

[7] Swedish Med Ctr, Seattle, WA USA

[8] Univ Arizona, Tucson, AZ 85721 USA

[9] Univ Calif San Diego, San Diego, CA 92103 USA

[10] AbbVie Inc, N Chicago, IL USA

[11] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1182/blood.V126.23.254.254

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4